Five things for pharma marketers to know: The Food and Drug Administration announced it is investigating whether CAR-T therapy, which uses genetically modified white blood cells to attack tumors, can in rare cases cause...

Biopharmaceutical companies, Gilead Sciences and Galapagos NV announced that the Marketing Authorization Application (MAA) for filgotinib, an investigational, oral, selective JAK1 inhibitor, for the treatment of adults

EC approves Pfizer’s Multiple Myeloma Drug Elrexfio Pfizer has announced that the European Commission (EC) has granted conditional marketing authorisation for Elrexfio (elranatamab) for the treatment of adult...